AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Trinity Biotech to sell $25 M of American depositary shares.
(From Chemical Business NewsBase - Press Release)
Trinity Biotech plc has obtained commitments from a select group of institutional investors in the USA and Europe to purchase about 2.675 M American Depositary Shares (ADS) at a price of $8.6/ADS in a registered public offering. This represents a discount of 4.5% to the closing price on Nasdaq on 5 Apr 2006. In addition, Ronan O' Caoimh, Trinity Biotech's CEO, has agreed to purchase about 223,460 American Depositary Shares from Trinity Biotech, at a price of $8.95/ADS, the closing bid price on 5 Apr 2006, for total proceeds of about $2 M. The closing for this purchase is scheduled to occur coincident with the closing …
